Cargando…

COVID-19 Antibody Seroconversion in Cancer Patients: Impact of Therapy Cessation—A Single-Center Study

Background: The effective development of COVID-19 vaccination has mitigated its harm. Using two laboratory methods, we investigated the efficacy of the BNT162b2 mRNA and BBIBP-CorV COVID-19 vaccines on seroconversion rates in cancer patients undergoing active cancer treatment. Methods: SARS-CoV-2 va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Souan, Lina, Abdel-Razeq, Hikmat, Nashwan, Sura, Al Badr, Sara, Alrabi, Kamal, Sughayer, Maher A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674399/ https://www.ncbi.nlm.nih.gov/pubmed/38005991 http://dx.doi.org/10.3390/vaccines11111659

Ejemplares similares

Comparative Assessment of the Kinetics of Cellular and Humoral Immune Responses to COVID-19 Vaccination in Cancer Patients
por: Souan, Lina, et al.
Publicado: (2023)

Extramedullary acute myeloid leukemia (eAML): Retrospective single center cohort study on clinico-pathological, molecular analysis and survival outcomes
por: Halahleh, Khalid, et al.
Publicado: (2021)

Comparison of the Immunogenicity and Protective Efficacy of Various SARS-CoV-2 Vaccines among Healthcare Workers: Are Our White Coat Armies Protected?
por: Souan, Lina, et al.
Publicado: (2022)

An update on the impact of SARS-CoV-2 pandemic public awareness on cancer patients' COVID-19 vaccine compliance: Outcomes and recommendations
por: Souan, Lina, et al.
Publicado: (2022)

Dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors: The evolution of a pandemic
por: Sughayer, Maher A., et al.
Publicado: (2021)

Non-Dexamethasone Corticosteroid Therapy’s Effect on COVID-19 Prognosis in Cancer Patients: A Retrospective Study
por: Souan, Lina, et al.
Publicado: (2023)

Changing trends in seroprevalence rates of transfusion-transmitted diseases among blood donors in Jordan
por: Souan, Lina, et al.
Publicado: (2021)

The Effect of Dexamethasone Treatment on COVID-19 Prognosis in Cancer Patients
por: Souan, Lina, et al.
Publicado: (2022)

Factors that predict severity of infection and seroconversion in immunocompromised children and adolescents with COVID-19 infection
por: Abu Shanap, Mayada, et al.
Publicado: (2022)

Current neoadjuvant treatment options for HER2-positive breast cancer
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2011)

Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies
por: Sughayer, M.A., et al.
Publicado: (2022)

The application of clinical variables and models to predict pulmonary embolism in cancer patients: a comprehensive single cancer center experience
por: Mansour, Asem, et al.
Publicado: (2013)

Clinical Characteristics, Prognostic Factors and Treatment Outcomes of Patients with Bone-Only Metastatic Breast Cancer
por: Marie, Lina, et al.
Publicado: (2022)

Venous thromboembolism prophylaxis for hospitalized medical patients, current status and strategies to improve
por: Abdel-Razeq, Hikmat
Publicado: (2010)

Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
por: Abdel-Razeq, Hikmat
Publicado: (2016)

Gonadotropin-releasing hormone agonists during chemotherapy for ovarian function and fertility preservation for patients with early-stage breast cancer
por: Abdel-Razeq, Hikmat
Publicado: (2019)

The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in long-distance travelers
por: Abdel-Razeq, Hikmat
Publicado: (2017)

Prognostic Significance of Serum Vitamin D Levels in Egyptian Females with Breast Cancer
por: Abdel-Razeq, Hikmat
Publicado: (2019)

Expanding the search for germline pathogenic variants for breast cancer. How far should we go and how high should we jump? The missed opportunity!
por: Abdel-Razeq, Hikmat
Publicado: (2021)

Surgical options for patients with early-stage breast cancer and pathogenic germline variants: an oncologist perspectives
por: Abdel-Razeq, Hikmat
Publicado: (2023)

COVID-19—Impact on DNR Orders in the Largest Cancer Center in Jordan
por: Shamieh, Omar, et al.
Publicado: (2020)

Oncology Medical Training and Practice: Managing Jordan’s Brain Drain Through Brain Train—The King Hussein Cancer Center Experience
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2020)

Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome – a comprehensive cancer center experience
por: Abdel-Razeq, Hikmat N, et al.
Publicado: (2011)

Changing Trends in Estrogen Receptors/Progesterone Receptors/Human Epidermal Growth Factor Receptor 2 Prevalence Rates Among Jordanian Patients With Breast Cancer Over the Years
por: Alsughayer, Anas M., et al.
Publicado: (2022)

Dealing with thrombocytopenia during anticoagulation with heparins for active venous thromboembolism: a play-it-safe practical approach
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2011)

Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2016)

Expanding the Clinical Use of CDK4/6 Inhibitors in the Treatment of Hormone Receptor-Positive, HER2-Negative Breast Cancer from Metastatic Setting to Adjuvant Setting
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2022)

Management Strategies of Breast Cancer Patients with BRCA1 and BRCA2 Pathogenic Germline Variants
por: Edaily, Sarah, et al.
Publicado: (2022)

Treatment options for patients with hormone receptor-positive, HER2-negative advanced-stage breast cancer: maintaining cyclin-dependent kinase 4/6 inhibitors beyond progression
por: Horani, Malek, et al.
Publicado: (2023)

Metaplastic Breast Carcinoma: Experience of a Tertiary Cancer Center in the Middle East
por: Erjan, Ayah, et al.
Publicado: (2021)

Complete and Durable Response to Tamoxifen and Ovarian Ablation in the Treatment of Metastatic Breast Cancer
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

Prolonged Neutropenia and Yellowish Discoloration of the Skin, But Not the Sclera, Following Excessive Turmeric Raw Root Ingestion
por: Abdel-Razeq, Rashid, et al.
Publicado: (2021)

Ethical Considerations for Treating Cancer Patients During the SARS-CoV-2 Virus Crisis: To Treat or Not to Treat? A Literature Review and Perspective From a Cancer Center in Low-Middle Income Country
por: Al-Tabba', Amal, et al.
Publicado: (2020)

Breast Cancer in Geriatric Patients: Current Landscape and Future Prospects
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2022)

Vitiligo-Like Lesions in a Patient with Metastatic Breast Cancer Treated with Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor: A Case Report and Literature Review
por: Sharaf, Baha', et al.
Publicado: (2022)

Patterns and Prevalence of Germline BRCA1 and BRCA2 Mutations among High-Risk Breast Cancer Patients in Jordan: A Study of 500 Patients
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2020)

Trends, Patterns, and Treatment Outcomes of Cancer Among Older Patients in Jordan: A Retrospective Analysis of National Cancer Registry and Institutional Outcome Data
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2020)

Breast Cancer Care in Jordan
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2020)

Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2018)

Prevalence and predictors of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cplj48tg78bk1t4viihuntntdn